Journal
Clinical Cancer Research
Publication Date
7-1-2024
Volume
30
Issue
13
First Page
2729
Last Page
2742
Document Type
Open Access Publication
DOI
10.1158/1078-0432.CCR-23-3077
Rights and Permissions
Johanns TM, Garfinkle EAR, Miller KE, Livingstone AJ, Roberts KF, Rao Venkata LP, Dowling JL, Chicoine MR, Dacey RG, Zipfel GJ, Kim AH, Mardis ER, Dunn GP. Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma. Clin Cancer Res. 2024 Jul 1;30(13):2729-2742. doi: 10.1158/1078-0432.CCR-23-3077 This open access article is distributed under the Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. ©2024 The Authors; Published by the American Association for Cancer Research
Recommended Citation
Johanns, Tanner M; Garfinkle, Elizabeth A R; Miller, Katherine E; Livingstone, Alexandra J; Roberts, Kaleigh F; Rao Venkata, Lakshmi P; Dowling, Joshua L; Chicoine, Michael R; Dacey, Ralph G; Zipfel, Gregory J; Kim, Albert H; Mardis, Elaine R; and Dunn, Gavin P, "Integrating multisector molecular characterization into personalized peptide vaccine design for patients with newly diagnosed glioblastoma." Clinical Cancer Research. 30, 13. 2729 - 2742. (2024).
https://digitalcommons.wustl.edu/oa_4/3885
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
